NVAX - Novavax, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5252.49M
Enterprise Value 3464.28M
Trailing P/E N/A
Forward P/E 1-2.55
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)15.81
Price/Book (mrq)N/A
Enterprise Value/Revenue 329.07
Enterprise Value/EBITDA 6-3.30

Trading Information

Stock Price History

Beta (5Y Monthly) 1.95
52-Week Change 3-80.89%
S&P500 52-Week Change 321.24%
52 Week High 343.40
52 Week Low 33.54
50-Day Moving Average 36.23
200-Day Moving Average 35.26

Share Statistics

Avg Vol (3 month) 34.11M
Avg Vol (10 day) 33.51M
Shares Outstanding 532.12M
Float 26.3M
% Held by Insiders 10.64%
% Held by Institutions 121.36%
Shares Short (Jan 30, 2020) 45.85M
Short Ratio (Jan 30, 2020) 40.71
Short % of Float (Jan 30, 2020) 425.79%
Short % of Shares Outstanding (Jan 30, 2020) 418.20%
Shares Short (prior month Dec 30, 2019) 45.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3May 09, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)-922.83%

Management Effectiveness

Return on Assets (ttm)-44.37%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)15.97M
Revenue Per Share (ttm)0.73
Quarterly Revenue Growth (yoy)-67.60%
Gross Profit (ttm)-139.51M
EBITDA -140.68M
Net Income Avi to Common (ttm)-150.2M
Diluted EPS (ttm)-6.87
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)71.17M
Total Cash Per Share (mrq)2.68
Total Debt (mrq)331.7M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.13
Book Value Per Share (mrq)-7.44

Cash Flow Statement

Operating Cash Flow (ttm)-158.15M
Levered Free Cash Flow (ttm)-88.21M